“Safety of Once- or Twice-Daily Dosing of Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) in Patients With Nonvalvular Atrial Fibrillation: A NOAC-TR Study”. 2018. Biomolecules and Biomedicine 18 (2): 185-90. https://doi.org/10.17305/bjbms.2017.2279.